Monday, September 14, 2026

IBS Researchers Advance Conditional Gene Editing With Cross-Species Expansion of SCON System

Researchers at IBS expanded the SCON gene knockout technology, enhancing studies in zebrafish and human stem cells for precise gene control.

Korea Hydro & Nuclear Power Wins Electric Power Research Institute Tech Transfer Honor in Phoenix After $16.5M Inspection Savings

KHNP recognized for innovative steam generator inspection technology, achieving cost savings and enhancing safety at power plants.

Hong Seong-ho of Seoul St. Mary’s Hospital Becomes First in Asia-Pacific to Perform 1,000 Single-Port Robotic Urologic Surgeries

A South Korean medical team achieved 1,000 single-port robotic surgeries in urology, led by Professor Hong Seong-ho.

Tag: clinical trials

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

U.S. pharmaceutical companies’ China clinical trial security probe to conclude this week… Could biotech rivalry intensify?

A U.S. investigation into pharmaceutical trials in China may reshape global biotech strategies, impacting South Korean firms.

Shaperon Secures South Korean Patent for Pulmonary Fibrosis Drug Candidate NuPulin

Shaperon secures a South Korean patent for NuPulin, an oral drug for idiopathic pulmonary fibrosis, showing promising preclinical results.

AI-Powered Antibody Drug Development: Samsung Biologics and Protina’s Game-Changing License Agreement

Samsung Bioepis and Protina sign a licensing agreement to develop AI-designed antibody drugs, aiming for candidates by 2027.

ABL Bio to Launch Global Phase 3 Trial of ABL111 in December, Targeting First-Line Gastric Cancer Treatment

ABL Bio will begin global Phase 3 trials for its dual antibody gastric cancer treatment 'ABL111' this December after FDA discussions.

China’s Fosun Pharma invests $27.5 million in AriBio, boosting optimism for Korean Alzheimer’s drug

Fosun Pharma invests $27.5 million in South Korea's AriBio, boosting its Alzheimer’s drug development and global commercialization efforts.

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

GCCL Strengthens Global Clinical Trial Role: What This Means for Asia’s Biotech Industry?

GCCL aims to expand internationally as a central lab for clinical trials, enhancing services and leveraging competitive advantages.

Supply Chains, M&A and AI: As China Closes In, K-Bio Faces a Critical Window of Opportunity [BIO USA]

Korea's biotech industry faces challenges and opportunities amid global restructuring, emphasizing AI and support for startups at BIO USA 2026.

How Samsung’s Galaxy Watch and Alcedis are Revolutionizing Clinical Research with Real-World Data

Samsung Electronics partners with Alcedis to use Galaxy Watch data for drug development, enhancing clinical trials with wearable tech.

CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

Celltrion's CT-P72/ABP-102 shows strong efficacy against HER2 tumors, promising for treating various cancers with reduced toxicity.

How Hyundai BioScience’s XAFTY Could Revolutionize Ebola Treatment: A Free Supply Proposal

Hyundai Bio USA proposes to provide antiviral candidate XAFTY for free to Ebola-affected countries, aiming to combat the disease urgently.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.